Blackstone (BX) Commits $400 Million With Teva to Advance Duvakitug Clinical Development

Top 100 Places Where the Rich People Own Real Estate

On March 3, 2026, Blackstone Life Sciences, a specialized beingness sciences concern level of Blackstone Inc. (NYSE:BX), entered a $400 cardinal strategical backing statement with Teva Pharmaceuticals. The statement aimed astatine accelerating the objective improvement of duvakitug, a monoclonal antibody targeting TL1A. It is presently successful Phase 3 trials for ulcerative colitis and Crohn’s disease, pursuing the occurrence of Phase 2b data. Blackstone Inc. (NYSE:BX)’s concern is dispersed implicit 4 years, and the steadfast volition person regulatory milestones and debased single-digit planetary royalties upon FDA approval. Paris Panayiotopoulos, Senior Managing Director astatine Blackstone Life Sciences, gave the pursuing statement.

Duvakitug has the imaginable to beryllium a best-in-class therapy successful a ample and increasing space, and the Teva and Sanofi teams are good positioned to make and commercialize this important medicine.

In a much caller development, connected March 5, 2026, Barclays expert Benjamin Budish reinstated sum of Blackstone with an Equal Weight standing and a $126 terms target. Following a little regularisation period, the steadfast is covering the banal with unchanged ratings and net estimates.

Founded successful 1985, Blackstone Inc. (NYSE:BX) is the world’s largest alternate plus manager operating from its office successful New York.

While we admit the imaginable of BX arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 10 Best Stocks to Buy According to Elliott Investment Management and 10 Best Stocks to Invest successful During a Recession

Disclosure: None. Follow Insider Monkey connected Google News.